Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients

Background: Fibroblast growth factor 23 (FGF-23) and α-Klotho protein appear to have an important role in the pathogenesis of CKD-mineral and bone disorders. The aim of this study was to investigate the association of FGF-23 and α-Klotho levels with adverse clinical outcomes in patients with non-dia...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eleni Manou, Elias Thodis, Georgios Arsos, Ploumis Pasadakis, Stylianos Panagoutsos, Dorothea Papadopoulou, Aikaterini Papagianni
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2020-10-01
coleção:	Kidney & Blood Pressure Research
Assuntos:	chronic kidney disease fibroblast growth factor 23 soluble α-klotho mortality
Acesso em linha:	https://www.karger.com/Article/FullText/510351
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!